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DOI 10.1016/j.ccr.2009.12.008SUMMARYChronic exposure to tobacco smoke, which contains over 60 tumor-initiating carcinogens, is the major risk
factor for development of lung cancer, accounting for a large portion of cancer-related deathsworldwide. It is
well established that tobacco smoke is a tumor initiator, but we asked whether it also acts as a tumor
promoter once malignant initiation, such as caused by K-ras activation, has taken place. Here we demon-
strate that repetitive exposure to tobacco smoke promotes tumor development both in carcinogen-treated
mice and in transgenic mice undergoing sporadic K-ras activation in lung epithelial cells. Tumor promotion is
due to induction of inflammation that results in enhanced pneumocyte proliferation and is abrogated by IKKb
ablation in myeloid cells or inactivation of JNK1.INTRODUCTION
Currently, lung cancer is the leading cause of cancer-related
mortalities in men and women, and despite extensive anti-
smoking campaigns it still accounts for 15% of all new cancers
and 29% of all cancer deaths in the U.S. (Jemal et al., 2008).
Among lung cancers, pulmonary adenocarcinoma is the
predominant histological type (Jemal et al., 2008; Toh, 2009).
Tobacco smoking is the major risk factor, estimated to cause
87% of lung cancer cases in the U.S. (Hecht, 2002). Tobacco
smoke (TS) contains 4000 chemical agents, including over 60
carcinogens: polycyclic aromatic hydrocarbons and N-nitrosa-
mines, such as NNK [4-(methylnitrosamino)-1-(3-pyridyl)-buta-
none] and aromatic amines (Hecht, 2002). Conversion of these
compounds to reactive forms (metabolic activation) results in
formation of DNA adducts that cause many of the genetic
changes underlying lung cancer. Among these changes, K-ras-
activating mutations are early events in the pathway leading toSIGNIFICANCE
Tobacco smoking accounts for the majority of lung cancer-re
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destruction in chronic obstructive pulmonary disease (COPD)
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to contribute to tumor initiation through the production of reac-
tive oxygen and nitrogen species that contribute to DNA damage
and induction of oncogenic mutations (Hussain et al., 2003), the
major effect of inflammation on tumor induction in experimental
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Tobacco Smoke Promotes Lung Cancer by Inflammationincrease lung cancer risk (Tockman et al., 1987), K-ras activation
in bronchial epithelial cells can cause an inflammatory response
(Ji et al., 2006), and autocrine production of the chemokine
CXCL-8 (IL-8) stimulates the growth of K-ras-transformed lung
adenocarcinoma cells (Karin, 2005; Sparmann and Bar-Sagi,
2004), the role of inflammation in smoking-induced lung tumori-
genesis remains to be investigated using appropriate in vivo
models. However, in none of the mouse models where TS or
compounds derived from it can induce lung cancer was TS
shown to act on a different step in the tumorigenic process other
than initiation (i.e., induction of oncogenic mutations).
Indeed, previous attempts to ascribe tumor-promoting activity
to TS in mice have failed (Witschi, 2005). In fact, mice that were
first treated with a carcinogen and subsequently exposed to TS
for 5 months showed a significant inhibition of tumor develop-
ment rather than enhancement (Witschi et al., 1997). After
a 4 month recovery phase, TS-exposed mice exhibited the
same tumor multiplicity as mice treated with carcinogen alone
(Witschi et al., 1997). In NNK-treated mice, TS exposure also
failed to increase lung tumor multiplicity (Finch et al., 1996). It
has been recognized that in thesemurinemodels of TS exposure
lung tumorigenesis is influenced by smoke-induced toxicity,
manifested by weight loss, thereby necessitating the inclusion
of a recovery period (Witschi, 2005). It was also noted that
long-term exposure desensitizes mice to TS, as maximal induc-
tion of pulmonary inflammation and cell proliferation were
observed 1 to 3 weeks after initiation of TS exposure (Witschi
et al., 1997). Furthermore, TS exposure can inhibit the metabolic
activation of NNK and reduces the formation of NNK-induced
O6-methylguanine DNA adducts (Brown et al., 1999), which
strongly correlate with lung tumor yield in A/J mice (Peterson
and Hecht, 1991). Taking all of these limitations into consider-
ation, we have devised two murine models in which intermittent,
yet prolonged, exposure to mainstream TS (MTS) can success-
fully promote lung tumor development. We have used these
models to determine how the tumor-promoting effect of MTS
exposure is accomplished.
RESULTS
To better understand how exposure to TS, which contains many
tumor initiators as well as irritants, promotes development of
lung cancer, we sought to develop mouse models in which
MTS exposure acts as a tumor promoter in addition to its estab-
lished tumor initiator activity. In the first model, we used NNK as
a tumor initiator and MTS as a tumor promoter. First, we opti-
mized the initiating dose of NNK in A/J mice and found it to be
50–70 mg/kg (see Figure S1A, available online). Next, 1 week
after intraperitoneal (i.p.) NNK injection into 7-week-old A/J
mice, we exposed one group of mice to MTS generated by
burning of 4 cigarettes/day, 5 days per week for 1 month, fol-
lowed by a 1month rest interval, and repeated this regimen three
times. A second group was exposed to 2 cigarettes/day, 5 days
per week for 5 months, whereas the third group received filtered
air for the same duration, as a control (Figure 1A). All mice were
given a final recovery period of 4 months. Whereas MTS-
exposed mice failed to gain weight during the exposure period,
mice exposed to 4 cigarettes/day for 1 month rapidly resumed
weight gain and caught up with air-exposed mice during the90 Cancer Cell 17, 89–97, January 19, 2010 ª2010 Elsevier Inc.1 month rest interval (Figure 1B). Yet, mice that were continu-
ously exposed to 2 cigarettes/day showed a sustained reduction
in body weight.
We analyzed lung tumor multiplicity and incidence by micro-
scopic examination after serial sectioning of lungs at 350 mm
intervals as described previously (Curtin et al., 2004). Mice
administered 70 mg/kg NNK and exposed to 4 cigarettes/day
exhibited significantly increased NNK-initiated lung tumor multi-
plicity, as well as increased tumor incidence (Figures 1C and 1D).
Exposure to 2 cigarettes/day MTS also increased tumor multi-
plicity and the effect was most pronounced when combined
with the highest NNK dose that was tested—70 mg/kg
(Figure S1A). Alveolar adenoma was the most common histolog-
ical type in both air- and MTS-exposed mice, seen in about 70%
of each cohort. About 30% of the tumors in both air- and MTS-
exposed mice showed features of well-differentiated human
papillary adenocarcinoma, including nuclear enlargement,
prominent nucleoli, increased mitotic rate, and bronchial inva-
sion (Figure 1E and Figure S1B).
Because the most common mutation found in murine lung
tumors induced by NNK is a GGT / GAT transition in codon
12 of the K-ras gene (Hecht, 1998), we developed a second
model in which we investigated whether intermittent MTS expo-
sure could promote K-ras-driven lung tumorigenesis using
K-rasLA2+/ (K-rasLA2) mice, which develop lung cancer in
response to sporadic activation of an oncogenic K-rasasp12 allele
through a spontaneous homologous recombination event (John-
son et al., 2001). Six- to eight-week-old, sex-matched K-rasLA2
mice were exposed toMTS at 4 cigarettes/day for 2–3weeks fol-
lowed by 2 week rest intervals on air alone, three times, and lung
tumors were analyzed at 5 months of age (Figure 2A). In contrast
to A/J mice, weight reduction in K-rasLA2 mice, which are in the
C57BL6 background, was more modest and occurred only
during the initial two cycles of MTS exposure (Figure 2B). As
found in NNK-initiated mice, MTS exposure increased tumor
multiplicity and maximal tumor sizes (Figures 2C and 2D). No
tumors were found in MTS-exposed wild-type (WT) mice
(Figure 2C), indicating that increased tumor number in MTS-
exposed K-rasLA2 mice is not due to MTS-induced tumor initia-
tion. Similar effects were observed in male and female mice
(Figures S2A and S2B). K-rasLA2 mice also develop thymic
lymphoma due to K-rasasp12 activation in thymocytes (Johnson
et al., 2001). No statistically significant differences in the inci-
dence of thymic lymphoma were detected between air- and
MTS-exposed K-rasLA2 mice (Figure S2C), suggesting that the
tumor-promoting effect of MTS is limited to the primary site of
exposure—the lung. Most pulmonary tumors in air- or MTS-
exposed K-rasLA2 mice were alveolar adenomas (Figure 2E and
Figure S2D), corresponding to a relatively early stage of lung
cancer development, as reported previously (Johnson et al.,
2001). Interestingly, tumors in MTS-exposed mice were more
vascularized than those in air-exposed controls (Figures S2E
and S2F). Thus, MTS exposure promotes development of both
chemically and genetically induced lung cancer and this consti-
tutes strong evidence that TS acts as a tumor promoter and not
only as an initiator.
We investigated whether the tumor-promoting effect of MTS
exposure is due to induction of inflammation. We examined the
subacute inflammatory pulmonary response of C57BL6 male
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Figure 1. Tobacco Smoke Exposure Promotes Development of
Chemically Induced Lung Cancer
(A) Experimental protocols for promotion of NNK-induced lung cancer. Seven-
week-old male A/J mice were MTS exposed using two different regimens
starting 1 week after NNK injection. Tumor development was analyzed
9 months later.
(B) Effect of MTS exposure on weight gain in A/J mice. Results are means ±
SEM (air control: n = 12; 2 cigarettes/day: n = 12; 4 cigarettes/day: n = 13).
(C) Lung appearance (left) and histology (H&E stain; right) in A/J mice 9months
after initiation of the NNK + MTS protocol.
Cancer Cell
Tobacco Smoke Promotes Lung Cancer by Inflammationmice exposed to MTS or air. Total cell number and numbers of
various leukocyte types in bronchoalveolar lavage fluid (BALF)
were significantly increased 1 and 2 weeks after MTS exposure
(Figure 3A). MTS exposure induced the expression of various
inflammatory cytokine and chemokine mRNAs, such as Il1b,
Il6, Tnfa, Ccl3 (Mip1a), and Ccl2 (Mcp1) in the lung (Figure 3B).
Induction of most of these transcripts was maximal within 2
weeks of exposure initiation and declined at later time points
(Figure S3A). MTS exposure also induced secretion of TNF-
a and IL-6 by lung cells (Figure 3C) and stimulated mitogen-acti-
vated protein kinases, including extracellular signal-regulated
kinase (ERK) and c-Jun N-terminal kinase (JNK) (Figure 3D).
Similar induction of inflammatory response genes was seen
after MTS exposure of K-rasLA2 tumor-bearing mice (Fig-
ure S3B). MTS exposure modestly increased NF-kB DNA
binding activity (Figure 3D) and increased cell proliferation in
the lung (Figure 3E), without affecting basal rate of apoptosis
(Figure S3C). Proliferating cells in the alveolar zone of MTS-
exposed lungs were mainly alveolar epithelial cells and immune
cells (Figure S3D). As shown below, MTS exposure also
increased cell proliferation within lung adenomas. Both IL-6-
and TNF-a-deficient mice showed decreased MTS-enhanced
lung cell proliferation (Figure S3E), indicating the importance of
these inflammatory cytokines in MTS-induced cell proliferation.
Lung tumors in MTS-exposed K-rasLA2 mice exhibited enhanced
infiltration with IL-6-producing macrophages (Figure 3F and
Figure S3F).
IkB kinase b (IKKb), required for NF-kBactivation, links chronic
inflammation with carcinogenesis in a mouse model of colitis-
associated cancer (Greten et al., 2004) and is a critical regulator
of inflammatory cytokine production (Karin, 2006). To examine
the contribution of IKKb to MTS-induced subacute pulmonary
inflammation, we used IkkbDmye (LysM-Cre; IkkbF/F) mice that
specifically lack IKKb in the myeloid lineage (Greten et al., 2004)
because myeloid cells, including alveolar macrophages, are
a major source of inflammatory cytokines needed for initiation
and propagation of inflammatory responses (Barnes, 2008).
The efficiency of IKKb deletion in alveolar macrophages was
80%–90% (Figure 4A) and previous experiments have shown
that IKKb is not deleted in any cell type other thanmature macro-
phages and neutrophils (Greten et al., 2004). IkkbDmye mice
showed impairedMTS-inducedcell recruitment intoBALF,which
mostly affected neutrophils (Figure 4B), decreased induction of
Il6, Tnfa, Ccl3, and Ccl2mRNAs, as well as decreased secretion
of IL-6 and TNF-a by MTS-exposed lungs, relative to MTS-
exposed IkkbF/F mice (Figures 4C and 4D). IkkbDmye mice also
exhibited decreased MTS-induced cell proliferation (Figure 4E).
We also deleted IKKb in Clara cells that account for 70% of the
airway epithelium using CC10-Cre; IkkbF/F mice (Broide et al.,
2005). Clara cell-specific deletion of IKKb had only a modest
and statistically insignificant effect on MTS-induced cytokine(D) Lung tumor multiplicity and incidence were determined by serial sectioning
at 350 mm intervals. Incidence equals the number of tumor-bearing mice
divided by the number of mice in each group. Results are means ± SEM
(n is as described in B). Significant difference, *p < 0.03.
(E) Histological appearance of adenoma (left) and adenocarcinoma with bron-
chial invasion (right) in A/J mice given NNK and 4 cigarettes/day MTS. The
scale bar represents 100 mm. See also Figure S1.
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Figure 2. Tobacco Smoke Exposure Promotes Development of
Genetically Induced Lung Cancer
(A) Outline of the experimental protocol in which K-rasLA2 mice were exposed
to MTS and analyzed at 5 months of age.
(B) Effect of MTS exposure on weight gain in K-rasLA2 mice. Results are
means ± SEM (air control: n = 4; 4 cigarettes/day: n = 8).
(C) Lung appearance (left side) and histology (H&E stain; right side) in 5-month-
old K-rasLA2 or WT mice with or without MTS exposure.
(D) Lung tumor multiplicity and maximal tumor sizes were determined as
above. Results are means ± SEM (air control: n = 16; 4 cigarettes/day:
n = 18). Significant difference, *p < 0.002.
(E) Histological appearance of adenoma in MTS-exposed K-rasLA2 mice. The
scale bar represents 100 mm. See also Figure S2.
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92 Cancer Cell 17, 89–97, January 19, 2010 ª2010 Elsevier Inc.secretion and cell proliferation (Figures S4A and S4B). Its
effect on MTS-induced tumor promotion was therefore not
explored.
To investigate the role of myeloid cell IKKb in MTS-induced
lung tumor promotion, we crossed K-rasLA2 mice with IkkbDmye
or IkkbF/F mice and exposed the hybrid strains to MTS as
described above. Deletion of IKKb in myeloid cells significantly
reduced the effect of MTS exposure on lung tumor multiplicity
and maximal tumor sizes (Figures 5A and 5B). IKKb deletion in
myeloid cells also reduced tumor angiogenesis, especially in
MTS-exposed mice (Figures S2E and S2F). In agreement with
the reduction in IL-6 production, we observed decreased MTS-
induced STAT3 activation in K-rasLA2; IkkbDmye mice (Figures
S5A and S5B). As indicated above, IL-6 and TNF-a, whose
induction in MTS-exposed lungs requires IKKb in myeloid cells
in both tumor-free (Figure 4C) and in K-rasLA2 tumor-bearing
mice (Figure S3B), are essential for MTS-induced epithelial cell
proliferation (Figure S3E). Consistent with these findings, IKKb
ablation in myeloid cells reduced MTS-induced proliferation of
lung adenoma cells (Figure 5C). Myeloid cell IKKb ablation,
however, did not have a significant effect on apoptosis in lung
adenomas, which was slightly elevated upon MTS exposure
(Figure 5D). We also examined the effect of IKKb deletion in
myeloid cells on MTS-induced recruitment of various immune
cell types into lungs of K-rasLA2 tumor-bearing mice. As seen
in naive mice, IKKb ablation reduced the number of recruited
neutrophils (Gr1+ cells) but did not significantly impact the
MTS-induced recruitment of macrophages (F4/80+ cells) and
CD4+ T cells (Figures S5C and S5D). The reduction in neutrophil
count was supported by a marked reduction in expression of
myeloperoxidase mRNA that encodes a neutrophil-specific
oxidative enzyme. MTS exposure and IKKb deletion had
no significant effect on the abundance of lung CD8+ T cells.
Thus, IKKb in myeloid cells plays a critical role in the promotion
of K-rasasp12-induced lung cancer development by MTS,
most likely through the induction of inflammation, angiogenesis,
and tumor-promoting inflammatory cytokines that stimulate
the proliferation of both premalignant and malignant cells. Our
results rule out reduced apoptosis as a component of the
tumor-promoting effect of MTS exposure.
It has been suggested that activation of mitogen-activated
protein kinases, including JNK, contributes to COPD-associated
mucus overproduction and inflammation (Mercer and
D’Armiento, 2006). JNK activation is also required for optimal
induction of inflammatory cytokines (Karin and Gallagher,
2005). To investigate the role of JNK in MTS-induced inflamma-
tion, we analyzed the subacute response to MTS exposure in
Jnk1/ mice. Jnk1/ mice showed reduced induction of Il6,
Tnfa, Ccl3, and Ccl2 mRNAs, as well as decreased secretion
of IL-6 and TNF-a by lung tissue uponMTS exposure, compared
to WT mice (Figures 6A and 6B). Jnk1/ mice also exhibited
decreased induction of pneumocyte proliferation upon MTS
exposure (Figure 6C).
To examine the role of JNK1 in MTS-induced lung tumor
promotion, we crossed K-rasLA2 mice with Jnk1/ mice and
generated K-rasLA2; Jnk1/ hybrids that were exposed to
MTS. Ablation of JNK1 reduced the enhancing effect of MTS
on lung tumor multiplicity and maximal tumor sizes (Figures 6D
and 6E). We also found decreased MTS-induced STAT3
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Figure 3. Tobacco Smoke Induces Pulmo-
nary Inflammation and Cell Proliferation
(A) Total cell number and leukocyte populations in
BALF collected from C57BL6males 24 hr after last
MTS or air exposure. Cellular composition was
analyzed using cytospin preparations. Results
are means ± SEM (n = 8 for each group). Signifi-
cant difference, *p < 0.02 versus air control.
(B) Induction of inflammatory cytokine and chemo-
kine mRNAs in lungs of MTS-exposed C57BL6
males. Lung RNA was isolated 24 hr after last
MTS exposure and analyzed by real-time PCR.
Results are means ± SEM (n = 5 for each group).
Significant difference, *p < 0.03 versus air control.
(C) Elevated cytokine secretion by lungs of MTS-
exposed male mice. Fresh lungs were cut into
small pieces and incubated in medium at 37C
for 48 hr. Cytokines in culture supernatants were
measured by ELISA. Results are means ± SEM
(air control: n = 7; 4 cigarettes/day 1w: n = 9;
4 cigarettes/day 2w: n = 9). Significant difference,
*p < 0.02 versus air control.
(D) ERK and JNK activation and NF-kB DNA
binding activity in lungs of MTS-exposed mice.
Lung lysates and nuclear extracts prepared 4 hr
after last MTS exposure were analyzed by immu-
noblotting and EMSA. Nuclear protein content
was determined by immunoblotting with b-actin
antibody. Shown are results from two representa-
tive mice per group.
(E) Cell proliferation in lungs of air- or MTS-
exposed mice was determined by BrdU labeling.
Results are means ± SEM (air control: n = 7;
4 cigarettes/day 1w: n = 5; 4 cigarettes/day 2w:
n = 8). Significant difference, *p < 4.0 3 105
versus air control.
(F) Infiltration of IL-6-positive macrophages into
K-rasLA2 lung tumors 2 weeks after initiation of
MTS exposure. Lung sections prepared 24 hr after
last MTS exposure were analyzed by immunos-
taining for F4/80 (green) and IL-6 (red). Nuclei
were counterstained by DAPI (blue). Scale bar =
100 mm. Results shown are for one representative
mouse. For quantitation of the entire experiment
see Figure S3F. See also Figure S3.
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Tobacco Smoke Promotes Lung Cancer by Inflammationactivation in K-rasLA2; Jnk1/ mice (Figures S6A and S6B).
Therefore, JNK1 also plays a significant role in the promotion
of lung inflammation and tumorigenesis subsequent to MTS
exposure.
DISCUSSION
TS exposure accounts for the majority of lung cancer-related
deaths in men and women (Hecht, 1999). Despite the identifica-
tion of numerous tumor-initiating carcinogens, such as NNK
(Hecht, 1999), the mechanism by which prolonged TS exposure,
either active or passive, enhances lung tumorigenesis is not well
understood due to the paucity of proper experimental models
that faithfully replicate different features of TS-induced lung
tumorigenesis in a small animal species amenable to geneticanalysis, i.e., the laboratory mouse. We now describe two
mouse models in which TS exposure has a well-defined tumor-
promoting effect on both chemically (NNK) and genetically
(K-rasasp12) induced lung cancer.We show that in both NNK-initi-
ated A/J mice and C57BL6 mice in which lung cancer has been
initiated through expression of an oncogenic K-rasasp12 allele,
MTS exposure increases tumor multiplicity, incidence, and
size. Consistent with being a tumor promoter under our experi-
mental conditions, MTS exposure had no discernable effect on
tumor histology, although tumor size was clearly increased along
with an enhanced tumor angiogenesis. Although tumor promo-
tion may be attributed to several factors, induction of inflamma-
tion, which elevates the production of inflammatory cytokines
that enhance the proliferation and survival of initiated epithelial
cells, is likely to be a major tumor-promoting mechanism (Karin,Cancer Cell 17, 89–97, January 19, 2010 ª2010 Elsevier Inc. 93
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Figure 4. Myeloid Cell IKKb Deletion Decreases MTS-Induced Inflammation and Cell Proliferation
(A) Expression of IKKb in alveolar macrophages of 7-week-old IkkbF/F and IkkbDmye mice.
(B) BALF cellular composition in air- or MTS-exposed IkkbF/F and IkkbDmye mice 24 hr after last MTS exposure. Results are means ± SEM (IkkbF/F air control: n = 9;
IkkbF/F 4 cigarettes/day 2w: n = 9; IkkbDmye air control: n = 9; IkkbDmye 4 cigarettes/day 2w: n = 13). Significant difference, *p < 0.03.
(C) Induction of inflammatory cytokine and chemokine mRNAs in lungs of MTS-exposed IkkbF/F and IkkbDmye mice 24 hr after last 1 or 2 weeks of MTS exposure.
Results are means ± SEM (n = 5 for each group). Significant difference, *p < 0.05.
(D) Secretion of cytokines by lungs of MTS-exposed mice was analyzed as in Figure 3C. Results are means ± SEM (IkkbF/F air control: n = 14; IkkbF/F 4 cigarettes/
day 2w: n = 8; IkkbDmye air control: n = 12; IkkbDmye 4 cigarettes/day 2w: n = 13). Significant difference, *p < 0.04.
(E) Cell proliferation in lungs of air- or MTS-exposed mice was analyzed as in Figure 3E. Results are means ± SEM (n = 7 for each group). Significant difference,
*p < 0.03. See also Figure S4.
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Tobacco Smoke Promotes Lung Cancer by Inflammation2006). Here we demonstrate that induction of a low grade
(subacute) inflammatory response is an important contributor
to the tumor-promoting activity of TS, leading to the enhanced
proliferation of both premalignant and malignant pulmonary
epithelial cells.
Interference with this inflammatory response through myeloid
cell-specific IKKb ablation resulted in nearly complete abroga-
tion of MTS-induced tumor promotion, but had little effect,
if any, on K-rasasp12-induced tumor initiation. These findings
should be contrasted with the importance of autocrine
chemokine production for the growth and progression of already
established and transplantable lung adenocarcinomas (Karin,
2005; Sparmann and Bar-Sagi, 2004). Although Ras-induced
CXCL-8 (IL-8) produced by lung adenocarcinoma cells is a che-
moattractant for myeloid cells (macrophages and neutrophils)
and it and other K-ras-induced chemokines can cause severe
pulmonary inflammation in mice (Ji et al., 2006), the mechanism
through which such chemokines exert their tumor-promoting
effect was not defined (Karin, 2005). Our results suggest that
one possible mechanism by which myeloid cells promote tumor
growth is through the IKKb/NF-kB-dependent production of
cytokines, such as IL-6 and TNF-a, both of which stimulate the94 Cancer Cell 17, 89–97, January 19, 2010 ª2010 Elsevier Inc.proliferation of pulmonary epithelial cells. These or other cyto-
kines and chemokines may also enhance tumor angiogenesis.
Previous work on the tumor-promoting role of inflammation
has been focused on cancers that are associated with either
chronic inflammatory disease, such as colitis associated cancer
(Greten et al., 2004; Grivennikov et al., 2009), or persistent viral
and bacterial infections, such as hepatocellular carcinoma
(Maeda et al., 2005; Pikarsky et al., 2004) and gastric cancer
(Tu et al., 2008). The present work has addressed the role of
inflammation in the tumorigenic effect of an environmental irri-
tant, TS, with a major public health impact as being responsible
for 25% of all cancer-related deaths in the U.S. Although
tobacco smoking increases colonization of the airways with
inflammation-causing bacteria (Saetta et al., 1994), it also
delivers irritants that are capable of direct induction of inflamma-
tion, a property sharedwith other inhaledmicroparticles, such as
asbestos and silica (Borm and Driscoll, 1996). Whereas chronic
inflammation lasting for decades, such as in long term smokers,
may lead to induction of oncogenic mutations through the
production of reactive oxygen and nitrogen species (Hussain
et al., 2003), it also leads to activation of NF-kB, AP-1, and other
transcription factors in airway myeloid cells, resulting in elevated
*0
20
40
60
80
*
A
B
* *
* *
C
0
2
4
6
D
K-rasLA2; IkkβF/F K-rasLA2; IkkβΔmye
4 
ci
g.
/d
ay
Ai
r c
on
tro
l
Tu
m
or
 m
ul
tip
lic
ity
0
40
80
120
160
K-rasLA2; IkkβF/F
K-rasLA2; IkkβΔmye
M
ax
im
al
 tu
m
or
 s
iz
e 
(m
m)
0
1
2
3
4 
cig
./d
ay
Ai
r c
on
tro
l
4 
cig
./d
ay
Ai
r c
on
tro
l
Pr
ol
ife
ra
tio
n 
in
 lu
ng
 tu
m
or
s
(C
ell
 nu
mb
er/
mm
2 )
Ap
op
to
sis
 in
 lu
ng
 tu
m
or
s
(C
ell
 nu
mb
er/
mm
2 )
4 
cig
./d
ay
 2w
Ai
r c
on
tro
l
K-rasLA2; IkkβF/F
K-rasLA2; IkkβΔmye
4 
cig
./d
ay
 2w
Ai
r c
on
tro
l
K-rasLA2; IkkβF/F
K-rasLA2; IkkβΔmye
Figure 5. IKKb Deletion in Myeloid Cells
Inhibits MTS-Induced Lung Tumor Promo-
tion and Malignant Cell Proliferation in
K-rasLA2 Mice
(A) Lung appearance (left) and histology
(H&E stain; right) in 5-month-old K-rasLA2; IkkbF/F
and K-rasLA2; IkkbDmye mice with or without MTS
exposure.
(B) Lung tumor multiplicity and maximal tumor
sizes were determined as in Figure 2D in K-rasLA2;
IkkbF/F and K-rasLA2; IkkbDmye mice that were
either air or MTS exposed. Results are means ±
SEM (K-rasLA2; IkkbF/F air control: n = 18; K-rasLA2;
IkkbF/F 4 cigarettes/day: n = 17; K-rasLA2; IkkbDmye
air control: n = 20; K-rasLA2; IkkbDmye 4 cigarettes/
day: n = 18). Significant difference, *p < 0.02.
(C) Cell proliferation in lung adenomas from air-
or MTS-exposed mice of indicated genotypes
was determined by BrdU labeling. Results are
means ± SEM (n = 5–6 for each group). Significant
difference, *p < 0.001.
(D) Apoptosis in lung adenomas from air- or
MTS-exposed mice of indicated genotypes
was determined by TUNEL staining. Results are
means ± SEM (n = 5–6 for each group). See also
Figure S5.
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Tobacco Smoke Promotes Lung Cancer by Inflammationcytokine production (Barnes, 2008). Our work based on shorter
term TS exposure in mice suggests that activation of IKKb and
JNK signaling pathways and induction of inflammatory cytokineA
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Figure 6. Deletion of JNK1 Decreases MTS-
Induced Inflammation, Cell Proliferation,
and Lung Tumor Promotion
(A) Induction of inflammatory cytokine and chemo-
kine mRNAs in lungs of MTS-exposed Jnk1/
mice was analyzed as in Figure 3B. Results are
means ± SEM (n = 5 for each group). Significant
difference, *p < 0.05.
(B) Secretion of cytokines in lungs of MTS-
exposed Jnk1/ mice was analyzed as in
Figure 3C. Results are means ± SEM (WT air
control: n = 12; WT 4 cigarettes/day: n = 9;
Jnk1/ air control: n = 9; Jnk1/ 4 cigarettes/
day: n = 9). Significant difference, *p < 0.05.
(C) JNK1 deletion decreases MTS-induced lung
cell proliferation. Results are means ± SEM (WT
air control: n = 7; WT 4 cigarettes/day: n = 8;
Jnk1/ air control: n = 10; Jnk1/ 4 cigarettes/
day: n = 9). Significant difference, *p < 0.0003.
(D) Lung appearance (left side) and histology
(H&E stain; right side) in 5-month-old K-rasLA2
or K-rasLA2; Jnk1/ mice with or without MTS
exposure.
(E) Lung tumor multiplicity and maximal tumor
sizes were determined as in Figure 2D. Results
are means ± SEM (K-rasLA2 air control: n = 16;
K-rasLA2 4 cigarettes/day: n = 18; K-rasLA2;
Jnk1/ air control: n = 13; K-rasLA2; Jnk1/
4 cigarettes/day: n = 14). Significant difference,
*p < 0.002. See also Figure S6.
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TS-enhanced tumorigenesis, it is likely that appropriate anti-
inflammatory therapy may slow down the development and
progression of lung cancer if administered early enough and
may interfere not only with tumor promotion but also with the
accumulation of further genetic changes. Our findings suggest
that it is also worthwhile to determine whether the great variation
in the incidence of lung cancer among smokers is associated
with genetic differences in TS-induced inflammation, as many
genetic polymorphisms are known to affect the inflammatory
response in the airways and other tissues (Cook et al., 2004).
Identification of the long suspected, but heretofore unproven,
tumor-promoting effect of TS provides a sound scientific ratio-
nale to the benefits of anti-inflammatory therapy or intervention
as well as for smoking cessation, which has to be practiced as
early as possible after detection of the smallest primary lung
tumor, if not earlier.
EXPERIMENTAL PROCEDURES
Animals
IkkbF/F, LysM-Cre; IkkbF/F (referred to as IkkbDmye), CC10-Cre; IkkbF/F, and
Jnk1/micewere described (Broide et al., 2005; Maeda et al., 2005).K-rasLA2
mice were provided by T. Jacks (Massachusetts Institute of Technology)
through the National Cancer Institute. Tnfa/, Il6/, and A/J mice were
from the Jackson Laboratory. All strains, except A/J mice, used in this study
were backcrossed to the C57BL6 background for more than six times. Mice
were maintained under specific pathogen-free conditions, and experimental
protocols were approved by University of California, San Diego Animal Care
Program, following National Institutes of Health guidelines.
NNK Treatment and Tobacco Smoke Exposure
For examining promotion of chemically-induced lung cancer, 7-week-oldmale
A/J mice were i.p. injected with 70 mg/kg NNK (Toronto Research Chemicals)
1 week before initiation of MTS exposure. Mice were exposed to MTS gener-
ated by burning 3R4F reference cigarettes (College of Agriculture, Reference
Cigarette Program, University of Kentucky) using a smoking machine
(McChesney-Jaeger CSM-SSM Single Cigarette Machine; CH Technologies)
regulated by programmable controls provided with JASPER windows 93/
2000 software over RS-232 communication ports (CH Technologies).
Each smoldering cigarette was puffed for 2 s, once every 25 s, for a total
of 12 puffs/cigarette, at a flow rate of 5 liters/min. Fresh smoke was diluted
with filtered air and delivered to a 12 port nose-only directed flow inhalation
exposure system (Jaeger-NYU 12 port). The average total suspended partic-
ulate matter monitored at nose ports was 173 ± 5.3 mg/m3. In the 4 ciga-
rettes/day exposure group, mice were exposed to MTS from 4 cigarettes/
day for 5 min per cigarette with a 5 min break between cigarettes, 5 days/
week for 1 month, followed by 1 month of rest. This cycle was repeated two
more times. In the 2 cigarettes/day group, mice were exposed to MTS from
2 cigarettes/day, administered over 5 min per cigarette with 5 min break
between cigarettes, 5 days/week for 5 months. Control mice were kept on
filtered air. Lung tumors were analyzed 9 months after initiation of NNK plus
MTS exposure. For examining promotion of genetically induced lung tumors,
6- to 8-week-old K-rasLA2 mutant mice were exposed to MTS at 4 ciga-
rettes/day, 5 days /week for 3 weeks, followed by a 2 week rest interval on
air alone, two times and exposed to MTS at 4 cigarettes/day, 5 days/week
for 2 more weeks. Sex-matched control K-rasLA2 mutant mice were kept on
filtered air. Lung tumors were analyzed at 5 months of age. For the NNK
dose optimization study, 7-week-old male A/J mice were i.p. injected with
30, 50, or 70 mg/kg NNK one week before initiation of MTS exposure. Mice
were exposed to 2 cigarettes/day MTS for 2 months and 1 cigarettes/day
for 3 months. Control mice were kept on filtered air. Lung tumors were
analyzed 9 months after NNK injection. In the subacute inflammation study,
7- to 8-week-old sex-matched mice were exposed to 4 cigarettes/day MTS,
5 days/week for 1 or 2 weeks. Control mice were kept on filtered air.96 Cancer Cell 17, 89–97, January 19, 2010 ª2010 Elsevier Inc.BrdU Labeling
For examining pulmonary cell proliferation, randomly chosen mice were i.p.
injectedwith100mg/kgBrdU (Sigma-Aldrich) 2 hrprior to sacrifice, andparaffin
sectionswere stainedwith aBrdU in situ detection kit (BDBiosciences). 3000 to
5000 cells per lung were counted in randomly selected fields. BrdU labeling
index was calculated as the percentage of labeled cells per total cells counted.
BALF Leukocyte Counts and Alveolar Macrophage Isolation
Number of total cells and leukocyte types in BALF were determined as
described previously (Ikeda et al., 2003). In brief, after instillation of 800 ml
sterile PBS through the trachea, BALF was withdrawn, and cytospin prepara-
tions of BALF cells were prepared using Shandon Cytospin centrifuge (Shan-
don Lipshaw). BALF cells were visualized by Wright-Giemsa staining and
percentages of leukocyte types were determined by counting 400 leukocytes
in a randomly selected portion of the slide under light microscopy. BALF total
leukocyte counts were performed using a hemocytometer. Alveolar macro-
phages were isolated as previously described (Vlahos et al., 2006).
Evaluation of Lung Tumors
For determining tumor incidence, multiplicity, and maximal sizes, whole lungs
weremanually inflatedwith and fixed in 4%paraformaldehyde for at least 24 hr
and paraffin embedded. Paraffin-embedded lungs were serially sectioned at
350 mm and histologically examined with hematoxylin and eosin (H&E) stained
sections as previously described (Curtin et al., 2004).
Cytokine ELISA
Fresh lung lobes were cut into small pieces and incubated in 1 ml RPMI
medium (Invitrogen) at 37C for 48 hr. IL-1b, IL-6, and TNF-a were measured
by enzyme-linked immunosorbent assay (BD Biosciences, eBioscience, and
R&D) with culture supernatants.
Analysis of Gene Expression
Total tissue RNA was prepared with RNeasy plus mini kit (QIAGEN). Quantita-
tive PCR was performed as described (Kim et al., 2009). RNA was reverse-
transcribed with SuperScript III First-Strand Synthesis System for RT-PCR
(Invitrogen). Real-time PCR was performed using SYBR green (Bio-Rad) on
a Bio-Rad iQ5 machine. Expression data were normalized to b-actin mRNA
amounts. Primer pairs for Il1b, Il6, Tnfa, Ccl2, and Ccl3 were as follows: 50-CA
ACCAACAAGTGATATTCTCCATG-30/50-GATCCACACTCTCCAGCTGCA-30;
50-GAGGATACCACTCCCAACAGACC-30/50-AAGTGCATCATCGTTGTTCATA
CA-30; 50-GACCAGGCTGTCGCTACATCA-30/50-CGTAGGCGATTACAGTCAC
GG-30; 50-GCAGGTCCCTGTCATGCTTC-30/50-TCCAGCCTACTCATTGGGAT
CA-30; 50-TGGAGCTGACACCCCGAC-30/50-ACGATGAATTGGCGTGGAA-30,
respectively. Primer pairs for myeloperoxidase were 50-CACCCTCTTTGTTC
GAGAGC-30/ 50-CAACACCAAGGGCAGGTAGT-30.
Biochemical and Immunohistochemical Analyses
Nuclear proteins were isolated from lung tissues using Nuclear Extract Kit
(Active Motif), and EMSA was performed using Gelshift Kit (Active Motif) and
a kB site consensus oligonucleotide (Promega). Nuclear extracts were
analyzed by SDS-PAGE and immunoblotting with antibody to b-actin
(Sigma-Aldrich). Total tissue lysates were prepared and analyzed by SDS-
PAGE and immunoblotting with antibodies to P-JNK, ERK, P-ERK (all from
Cell Signaling), JNK (BD Biosciences), and IKKb (Millipore). Apoptosis was
determined with ApopTag Red In Situ Apoptosis Detection Kit (Millipore).
For immunohistochemistry, paraffin-embedded slides were deparaffinized
and antigens were unmasked by incubation at 94C for 40 min in Target
Retrieval Solution S1700 (Dako). Slides were incubated with primary anti-
bodies in 4C overnight. Signals were detected with fluorescent microscopy
or VECTASTIN ABC Elite kit (Vector Laboratories), DAB Substrate Kit (Vector
Laboratories), and light microscopy. The following antibodies were used:
anti-IL-6-PE, anti-P-STAT3 (both from Cell Signaling), anti-F4/80-Alexa488
(Caltag), anti-CD31 anti-CD4, anti-CD8 (all three from BD Biosciences), anti-
F4/80, and anti-Gr-1 (both from eBioscience).
Statistical Analysis
Results are expressed as means ± SEM. Data were analyzed by Student’s
t test and Fisher’s exact test. p values < 0.05 were considered significant.
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